Suggestions appear as you type. Use the up and down arrows to choose one and Enter to open it.

This page's audience our own tag's counts — open to see them
–Visits
–Page views
–Clicks to vendors
–Time on page
–Reading now
Clicks to vendors, by tool
  • –
Top countries
  • –
Devices
  • –

– · visits, page views and clicks counted by our own tag, which counts more than our checked analytics; every figure rounded down · how we count

Head-to-head · AI Drug Discovery Software

Recursion vs Iktos

  • Updated Oct 2026
  • Both researched from official sources
  • 4 checks side by side
Higher score Recursion #3 in AI Drug Discovery Software 8.7/10 Pricing on request ✓ 3 of 4 features Visit Recursion
Iktos #5 in AI Drug Discovery Software 7.9/10 Pricing on request ✓ 3 of 4 features Visit Iktos

Recursion leads on 0 checks, Iktos on 0, and 4 are even. Who comes out ahead on the 4 yes/no, price and count checks where we have data for both products. The editor score weighs everything else too.

Our verdict

  • Highest scoreRecursion · 8.7/10

Recursion scores higher on our rubric for ai drug discovery software: 8.7 against 7.9 out of 10; our editors rank them #3 and #5.

Recursion is the better fit for teams linking computational discovery to experiments. Iktos is the better fit for teams combining molecular design with automated testing.

  • Recursion fits best

    Teams linking computational discovery to experiments

  • Iktos fits best

    Teams combining molecular design with automated testing

Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. Bought places stand at the number bought; this page and our disclosure say so. Paying vendors may get a fuller, more detailed review from our editors, and that review can change their score. How we rank.

Side by side

Feature Recursion 8.7/10 Visit ↗ Iktos 7.9/10 Visit ↗
At a glance
Editor score 8.7 7.9
Ranking #3 in AI Drug Discovery Software #5 in AI Drug Discovery Software
Best for Teams linking computational discovery to experiments Teams combining molecular design with automated testing
Pricing model Paid Paid
Starting price Pricing on request Pricing on request
Free plan — Not checked yet
Free trial — —
Built for Mid-market, Enterprise Mid-market, Enterprise
Features Recursion 3/4 · Iktos 3/4
Target identification ✓ ✓
Molecule design ✓ ✓
Drug repurposing Not checked yet Not checked yet
Research publications ✓ ✓
Specs
Discovery scope Suite Suite
Deployment options Not checked yet Both
Our review
Pros
  • Connects target identification, molecule design and ADMET computation.
  • Combines machine-learning analysis of biological and chemical data.
  • Schedules synthesis and experiments, with results feeding computational workflows.
  • Generates molecules against target product profile constraints
  • Combines SAR, ADMET, and multi-parameter compound scoring
  • Connects design with automated synthesis and biological testing workflows
Cons
  • No free plan is available.
  • Pricing is handled through sales rather than public plan tiers.
  • The proprietary Recursion OS is not open source.
  • Pricing is available through contact sales
  • The listed support channel is email
  • The platform's components and workflows may call for specialist drug-discovery teams
Our verdict

Recursion OS brings computational drug discovery and physical experimentation into one platform, with workflows that span target identification through molecule design and onward into development. Its capabilities include machine-learning…

Read the review →

Iktos brings molecule design, retrosynthesis, and laboratory automation into a drug-discovery suite for pharmaceutical, biotech, and academic teams. Makya supports ligand- and structure-based molecular modeling, with target product profile…

Read the review →
  1. RecursionAI Drug Discovery Software 8.7Pricing on request
  2. IktosAI Drug Discovery Software 7.9Pricing on request

Strengths and trade-offs

  • Recursion — where it wins

    • Connects target identification, molecule design and ADMET computation.
    • Combines machine-learning analysis of biological and chemical data.
    • Schedules synthesis and experiments, with results feeding computational workflows.

    Where it doesn't

    • No free plan is available.
    • Pricing is handled through sales rather than public plan tiers.
    • The proprietary Recursion OS is not open source.

  • Iktos — where it wins

    • Generates molecules against target product profile constraints
    • Combines SAR, ADMET, and multi-parameter compound scoring
    • Connects design with automated synthesis and biological testing workflows

    Where it doesn't

    • Pricing is available through contact sales
    • The listed support channel is email
    • The platform's components and workflows may call for specialist drug-discovery teams
  • Recursion8.7/10 · Pricing on request

    A broad discovery suite for teams connecting computational models with lab experiments.

    Visit RecursionFull verdict →
  • Iktos7.9/10 · Pricing on request

    A drug-discovery suite linking constrained molecule design to automated synthesis and testing.

    Visit IktosFull verdict →

More comparisons

All AI drug discovery software comparisons → · Full ranking →

Guides on AI drug discovery software

Reviewed by iTechGuides Editors · Editorial team · Updated Oct 2026

Last updated · How we research and update